Request Deal Involvement

Novo Holdings, Jeito Capital and Asabys Partners led a €78m Series A round in Augustine Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

ICR

pr advisors

ICR

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Alantra

financial advisors

Alantra

or

Principals

V-BIO VENTURES

bidder

V-BIO VENTURES

AUGUSTINE THERAPEUTICS NV

target

AUGUSTINE THERAPEUTICS NV

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

JEITO CAPITAL

bidder

JEITO CAPITAL

ASABYS PARTNERS

bidder

ASABYS PARTNERS

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

ADBIO PARTNERS

bidder

ADBIO PARTNERS

CHARCOT-MARIE-TOOTH (CMT) RESEARCH FOUNDATION

bidder

CHARCOT-MARIE-TOOTH (CMT) RESEARCH FOUNDATION

GEMMA FRISIUS FUND (GFF)

bidder

GEMMA FRISIUS FUND (GFF)

NEWTON BIOCAPITAL

bidder

NEWTON BIOCAPITAL

VIB

bidder

VIB

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo Holdings, Jeito Capital and Asabys Partners led a €78m Series A round in Augustine Therapeutics.